Generic Name and Formulations:
Lincomycin 300mg/mL; soln for IV, IM, subconjunctival inj after dilution; contains benzyl alcohol 9.45mg.
Indications for LINCOCIN:
Serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Reserved for penicillin-allergic patients or for whom penicillin is inappropriate.
IV doses: should be infused over at least 60 minutes. Serious infections: 600mg IM every 24hrs or 600mg–1g IV every 8–12hrs. More severe infections: 600mg IM every 12hrs (or more often), or doses up to 8g/day IV have been used for life-threatening infections. Subconjunctival inj: 75mg subconjunctivally will result in ocular fluid levels of antibiotic with MICs sufficient for most susceptible pathogens. Severe renal impairment: give 25–30% of recommended dose.
<1month: not recommended. ≥1month: Serious infections: 10mg/kg IM every 24hrs. More severe infections: 10mg/kg IM every 12hrs or more often. Depending on severity of infection, may also give 10–20mg/kg/day IV in divided doses.
Not for treating minor bacterial or viral infections, or meningitis. Discontinue if significant diarrhea, colitis occurs. History of GI disease (esp. colitis). History of asthma or significant allergies. Severe renal impairment. Hepatic dysfunction. Monitor liver, kidney, and blood counts with prolonged therapy. Premature infants (Gasping Syndrome from benzyl alcohol). Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.
Concomitant erythromycin: not recommended. May enhance the action of neuromuscular blocking agents.
GI upset, colitis, hematologic effects (eg, neutropenia, leukopenia, agranulocytosis, thrombocytopenic purpura), hypersensitivity reactions (discontinue if occurs), rash, urticaria, vaginitis, jaundice, abnormal LFTs, azotemia, oliguria, proteinuria, cardiopulmonary arrest and hypotension with rapid IV administration.
Vials (2mL, 10mL)—1